about
Structure and interaction with phospholipids of a prokaryotic lipoxygenase from Pseudomonas aeruginosaA large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.Draft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain.VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, SpainMolecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone.Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.The increasing threat of Pseudomonas aeruginosa high-risk clones.OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.Comparison of local features from two Spanish hospitals reveals common and specific traits at multiple levels of the molecular epidemiology of metallo-β-lactamase-producing Pseudomonas spp.Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.Sensing Mg2+ contributes to the resistance of Pseudomonas aeruginosa to complement-mediated opsonophagocytosis.Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system.In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa.Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis model.Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpCGenetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues.Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.Biological markers of Pseudomonas aeruginosa epidemic high-risk clones.NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosaAffinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa.Mobile genetic elements related to the diffusion of plasmid-mediated AmpC β-lactamases or carbapenemases from Enterobacteriaceae: findings from a multicenter study in SpainTransferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4')-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain.Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.VIM-47, a New Variant of the Autochthonous Metallo-β-Lactamase VIM-13 from the Balearic Islands in Spain.Gastroenteritis outbreaks in 2 tourist resorts, Dominican Republic.
P50
Q27679822-A17ED957-CA9C-4696-A2A4-86E0B6D2990DQ31034219-33A81377-FD22-44BA-A8C9-1C5016A29B38Q33422951-926333D6-C6D7-42F4-A92E-72C7DD780A2FQ34429763-5A7804DF-3653-452F-92E6-33227413812DQ36147987-480FC34D-69A8-426F-83E1-62B0F94BB22DQ36313186-099227B6-A37E-44FA-B390-A84271DE96ABQ36760871-160E2A71-FC89-4B08-8843-A7BFA722B76FQ37302114-7CAB4DC0-09AA-4DCA-9FDA-6BCF5411D41BQ37428703-F93C101E-2A2A-4359-9E82-A95D281DEEE4Q38309969-B10A34FD-29EA-4CCE-B40B-1C9C759FE9BBQ38573407-0C5BF561-67A3-4112-8137-5A3EAA49D4F5Q38626877-DA27F3E7-F5F6-4830-9AA3-0E2CB2E2E16CQ38626934-80B9C252-CE82-4593-B9BA-25F4968ACE66Q38741337-49641CE5-552F-471E-8450-5C5E0958C532Q38802410-F216984A-8E88-4EC0-98F0-DB34E2A68691Q39609617-49626D75-3240-44A1-AA27-0078AA3AA194Q39682878-FEECBBFB-56F5-4E0B-9903-48C6982B1C4CQ39850643-7CE1FF38-E9BF-4FC3-B60A-97C62D7665D7Q40094940-A1F986FD-60BA-4F49-85F1-74F77D63985DQ40120435-F4ACF225-9189-4F4A-87F9-198A2EC11187Q40148490-1A73FE9F-F8D0-4A8D-B2FD-ED3D4E453D06Q40401711-85986526-DF70-4702-A2A6-FD2800C05AB1Q40415181-C1FD7B5E-3303-497C-A45A-C038848EB919Q40882363-DD8E1CB6-3715-49BF-860D-162C91EF4159Q41075944-016BA38B-DE11-49C7-A0D1-E29128ECA685Q41183478-33183D56-71BF-4612-821F-FE64C32EC1D8Q41741069-147D1427-9226-4815-8347-55D1A799B0DFQ41834172-06942B00-7F67-4C9E-AE4E-638D1DED6FC6Q41839265-EBCC367D-7DBC-4180-A4DD-364FFD4E6A58Q42074076-EC7F50AC-FA36-40B7-8173-32450B978948Q42111506-9E6EC6B9-48E0-4A50-A4AE-D26E7601A617Q42249771-C801F5A4-6DB7-4923-90EF-B319A2E2C56DQ42430253-378B2216-3631-45B5-9FF2-2921693A3668Q42430254-083605AE-E4E1-49B3-971E-FFB64C1E86AAQ42547267-74B46135-0E7E-4C48-AA5A-4ACA53913BDFQ42559087-469D4C81-BB09-4274-8AC8-01986EE1A5E3Q42687443-3FFEE387-4650-43F3-9608-2305E0CE3002Q42706349-39814A0E-019B-4ECB-BF73-50ACB7BA359DQ42797383-486DF254-9C29-42BD-ABAE-8C423393734FQ42832232-3B4A8059-F233-4C0A-B9A7-80181445EC37
P50
description
Spaans onderzoeker
@nl
Spanish researcher
@en
investigador español
@ast
investigador español
@es
taighdeoir Spáinneach
@ga
name
Carlos Juan Nicolau
@an
Carlos Juan Nicolau
@ast
Carlos Juan Nicolau
@ca
Carlos Juan Nicolau
@da
Carlos Juan Nicolau
@de
Carlos Juan Nicolau
@es
Carlos Juan Nicolau
@eu
Carlos Juan Nicolau
@fr
Carlos Juan Nicolau
@gl
Carlos Juan Nicolau
@it
type
label
Carlos Juan Nicolau
@an
Carlos Juan Nicolau
@ast
Carlos Juan Nicolau
@ca
Carlos Juan Nicolau
@da
Carlos Juan Nicolau
@de
Carlos Juan Nicolau
@es
Carlos Juan Nicolau
@eu
Carlos Juan Nicolau
@fr
Carlos Juan Nicolau
@gl
Carlos Juan Nicolau
@it
altLabel
Carlos Juan Nicolau
@en
prefLabel
Carlos Juan Nicolau
@an
Carlos Juan Nicolau
@ast
Carlos Juan Nicolau
@ca
Carlos Juan Nicolau
@da
Carlos Juan Nicolau
@de
Carlos Juan Nicolau
@es
Carlos Juan Nicolau
@eu
Carlos Juan Nicolau
@fr
Carlos Juan Nicolau
@gl
Carlos Juan Nicolau
@it
P106
P21
P27
P31
P496
0000-0002-1402-3516